Bank Rakyat Indonesia: Company Update
Bank Rakyat Indonesia: Company Update
Bank Rakyat Indonesia: Company Update
INDONESIA EQUITY
Investment Research
Company Update
Rocky Indrawan
+65 6232 3832
rocky.indrawan@sg.oskgroup.com Bank Rakyat Indonesia
Favourable Risk-Reward Balance
BUY Short-term dampener. The feeble tone in BBRIs 3Q12 has caused weakness in share
Target IDR8800 price and we sensed that investors confidence was knocked by concerns of falling asset
yields and sluggish micro credit growth. Although we concur that contraction in NIM was
Previous IDR8800 a dampener, not all are doom and gloom: 1) segmental analysis suggests that interest
Price IDR7100 income growth was mostly dragged down by lower securities yields (-7% fall in interest
income YoY) and retail (-2% YoY) while interest income growth from micro although
BANKS
not exciting grew by 2% YoY; 2) on a net interest income basis, micro segment grew
Bank Rakyat Indonesia is Indonesias first
6% YoY; 3) we expect micro credit growth to pick up in 2013; 4) valuation is compelling.
state-owned bank and is among the
oldest in the country. Since its origination Stock may be muted in the near-term however it is attractive on a 12-month basis.
the bank has focused on micro, small and Maintain Buy.
medium enterprise segment.
Not all on micro weakness. Asset yields fell ~210bp YoY to offset ~70bp drop in
Stock Statistics average cost of funds and NIMs contracted to 8.8% in 9M12. Although mediocre micro
Bloomberg Ticker BBRI IJ credit growth (12.1% YTD) took some blame, one should note that higher corporate
Share Capital (m) 24,669 loans mix (25% of loans in the last 2 Qs), FX lending (over 40% growth YoY), lower
Market Cap (IDRb) 176,385 returns from securities and the impact of new accounting recognition on interest income
52 week H | L Price 7,850 | 5,150 were jointly margin negative. Micro contribution remains healthy at ~30% of loan book.
(IDR)
3mth Avg Vol (000) 27,768
YTD Returns (%) 5.9 Capacity to translate to intensity. BBRI is adding 7,000 new loan officers this year,
Beta (x) 1.26 another 2,000 next year to expand micro lending capacity. Given the required training
time, the newly recruited officers are likely to hit the ground by 4Q12-early 2013. Our
Major Shareholders (%) conversation with BBRI also suggested that micro credit growth could pick up in 4Q12
Indonesian Government 56.8 although in our view it may still be below 20% YoY.
Favourable risk-reward balance. Stock is now trading at 2013F 9.7x PE/ 2.2x PB
which is undemanding in our view at the same P/B multiple as BMRI but BBRI has
Share Performance (%)
higher ROAE. Though unlikely, worst case scenario could mimic performance post 1Q12
Month Absolute Relative
1m (7.1) (6.6) results which bear resemblance to 3Q12 results where BBRI dipped to 1.9x PB
3m 0.0 (3.8) before rallying 36%.
6m 20.2 12.8
12m 6.7 (8.9)
IDR
9,000
7,000
5,000
Sources : Company data and DMG estimates Sources : Company data and DMG estimates
NIM contraction was the weakest point in 9M12 and BBRI posted the poorest performance in
NIM relative to peers. Asset yields drop of 210bp YoY to 12.1% more than offset the 74bp
improvement in cost of funds to 3.4%. NIMs fell to ~8.8% from ~10.2% in 9M11
(Exhibit 1).
Although mediocre micro credit growth of 12.1% YTD (15.1% YoY) deserves some blame,
closer look suggests that it is erroneous to blame the fall in asset yields solely on micro
loans alone. Corporate loans have now made up ~24-25% of loan book for the past 2 Qs,
higher than the desired 20%. We further note that FX loans which bear lower yields than
IDR loans continued to grow rather strongly at 44% YoY as of 9M12.
We gather that these loans are to corporate SOEs and these are short-term avenues the
management is pursuing as: 1) management saw IDR3.3t of high-yield Government bonds
matured in early 3Q12; 2) returns offered by placements and securities are low; 3)
consolidation in SME is still continuing and micro business is being revamped. We believe
that a return to 20%-max corporate loan mix to total loan book is key to regain
some footing on asset yields and also to recover confidence.
Segmental analysis suggests that softness in interest income did not come from micro alone.
Retail loans interest income (38% of interest income) dropped 2% YoY and interest income
from securities (12% of interest income) fell 7% YoY. On the other hand interest income from
micro (40%) managed to grow by 2% while corporate (8%) and syariah (3%) interest income
expanded 15% and 38% respectively (Exhibit 3).
On net interest income basis, management disclosure suggests that micro net interest income
grew 6% YoY while corporate net interest income grew 3% (Exhibit 4), implying that BBRI
has some pricing power in deposit in the micro segment, which we view positively.
(IDRb) Nominal net interest income (LHS) Net interest income growth (RHS) (YoY %)
600 6.1 8
6
400 3.2
4
200 2
0 0
(2)
(200) (4.9) (2.2) (4)
(400) (6)
Micro Retail Corporate Others
Source: Company data and DMG research estimates
We concur that micro credit has to pick up, although it is unlikely that growth could hit above
30% seen in glory days few years back on the back of rising competition. Our conversation
with BBRI suggested that net micro disbursement has reached IDR1.9t in the month of
October alone and if we assume that BBRI manage to do equally well in the month of
November and December, IDR5.7t disbursement in 4Q12 could translate to 18% YoY micro
credit growth.
The market has now turned highly sceptical and somewhat pessimistic after two out of three
quarters of disappointment and although we are not convinced that this would be large
enough impetus for the stock to thrust forward, the pick up in growth could provide some
source of confidence.
2004
2005
2006
2007
2008
2009
2010
2011
2012
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
Sources : Company data and DMG estimates Sources : Company data and DMG estimates
Buy: Share price may exceed 10% over the next 12 months
Trading Buy: Share price may exceed 15% over the next 3 months, however longer-term outlook remains uncertain
Neutral: Share price may fall within the range of +/- 10% over the next 12 months
Take Profit: Target price has been attained. Look to accumulate at lower levels
Sell: Share price may fall by more than 10% over the next 12 months
Not Rated: Stock is not within regular research coverage
All research is based on material compiled from data considered to be reliable at the time of writing. However, information and opinions expressed
will be subject to change at short notice, and no part of this report is to be construed as an offer or solicitation of an offer to transact any securities or
financial instruments whether referred to herein or otherwise. We do not accept any liability directly or indirectly that may arise from investment
decision-making based on this report. The company, its directors, officers, employees and/or connected persons m ay periodically hold an interest
and/or underwriting commitments in the securities mentioned.
Distribution in Singapore
This research report produced by OSK Research Sdn Bhd is distributed in Singapore only to Institutional Investors, Expert Investors or
Accredited Investors as defined in the Securities and Futures Act, CAP. 289 of Singapore. If you are not an Institutional Investor, Expert Investor
or Accredited Investor, this research report is not intended for you and you should disregard this research report in its entirety. In respect of any
matters arising from, or in connection with, this research report, you are to contact our Singapore Office, DMG & Partners Securities Pte Ltd
(DMG).
All Rights Reserved. No part of this publication may be used or re-produced without expressed permission from OSK Research.
Bangkok